ACP Ohio Chapter (@acpohio.bsky.social)

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association diabetesjournals.org/care/article...

loading . . .

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), is a growing but often https://diabetesjournals.org/care/article/doi/10.2337/dci24-0094/160536/Metabolic-Dysfunction-Associated-Steatotic-Liver